19 December 2025
Baker McKenzie Advises HSBC on Parnell Pharmaceutical’s AUD 110,000,000 Noble Pharma Acquisition Financing
Advising firms
Deal team
3 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Hamish McCormack Lead | Baker McKenzie | Partner | leveraged finance | Australian |
| Leandros Pandoulis | Baker McKenzie | Associate | leveraged finance | Australian |
| Stephanie Vesel | Baker McKenzie | Associate | leveraged finance | Australian |
Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- AUD 110m (AUD 110,000,000)
- What the figure measures
- Facility amount
- Client
- The Hong Kong and Shanghai Banking Corporation LimitedLenders
- Counterparties
- Parnell Pharmaceuticals Holdings Pty Ltd (Borrower)
DW Healthcare Partners (Sponsor)